Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers
- PMID: 1725163
- DOI: 10.1111/j.1432-0436.1991.tb00255.x
Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers
Abstract
A defined cultivation system was developed for the differentiation of pluripotent embryonic stem cells of the mouse into spontaneously beating cardiomyocytes, allowing investigations of chronotropic responses, as well as electrophysiological studies of different cardioactive drugs in vitro. The beta-adrenoceptor agonists (-)isoprenaline and clenbuterol, the mediators of cAMP metabolism, forskolin and isobutylmethylxanthine (IBMX), the alpha 1-adrenoceptor agonist (-)phenylephrine, and the heart glycoside digitoxin induced a positive, the muscarinic cholinoceptor agonist carbachol and L-type Ca2+ channel blockers nisoldipine, gallopamil and diltiazem induced a negative chronotropic response. In early differentiated cardiomyocytes beta 1-, alpha 1-, but not beta 2-adrenoceptors, cholinoceptors, as well as L-type Ca2+ channels participated in the chronotropic response. In terminally differentiated cardiomyocytes beta 2-adrenoceptors and digitoxin responses were also functionally expressed. The contractions of spontaneously beating cardiomyocytes were concomitant with rhythmic action potentials very similar to those described for embryonic cardiomyocytes and sinus-node cells. We conclude that cardiomyocytes differentiating from pluripotent embryonic stem cells are able to develop adrenoceptors and cholinoceptors and signal transduction pathways as well as L-type Ca2+ channels as a consequence of cell-cell interactions during embryoid body formation in vitro, independent of the development in living organisms. The cellular system described may be useful as in vitro assay for toxicological investigations of chronotropic drugs and a model system for studying commitment and cellular differentiation in vitro.
Similar articles
-
Development of an in vitro cardiomyocytes cell model for embryotoxicological and pharmacological studies.ALTEX. 1992;9(2):29-42. ALTEX. 1992. PMID: 11178567 English.
-
Cardiomyocyte-like cells differentiated in vitro from embryonic carcinoma cells P19 are characterized by functional expression of adrenoceptors and Ca2+ channels.In Vitro Cell Dev Biol Anim. 1994 Jul;30A(7):425-34. doi: 10.1007/BF02631310. In Vitro Cell Dev Biol Anim. 1994. PMID: 7952511
-
Adrenergic-cholinergic interactions in left atria: interaction of carbachol with alpha- and beta-adrenoceptor agonists.Can J Physiol Pharmacol. 1986 May;64(5):597-601. doi: 10.1139/y86-099. Can J Physiol Pharmacol. 1986. PMID: 2873880
-
Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization.Mol Cell Biochem. 1995 Aug-Sep;149-150:103-26. doi: 10.1007/BF01076569. Mol Cell Biochem. 1995. PMID: 8569720 Review.
-
Actions of adrenergic and cholinergic drugs on renal tubular cells.Pharmacol Rev. 1992 Mar;44(1):81-102. Pharmacol Rev. 1992. PMID: 1557426 Review.
Cited by
-
The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating β-catenin-dependent transcription.Stem Cells. 2013 May;31(5):928-40. doi: 10.1002/stem.1332. Stem Cells. 2013. PMID: 23341242 Free PMC article.
-
Expansion and differentiation of germline-derived pluripotent stem cells on biomaterials.Tissue Eng Part A. 2013 May;19(9-10):1067-80. doi: 10.1089/ten.TEA.2012.0185. Epub 2013 Feb 26. Tissue Eng Part A. 2013. PMID: 23234562 Free PMC article.
-
Irx4 Marks a Multipotent, Ventricular-Specific Progenitor Cell.Stem Cells. 2016 Dec;34(12):2875-2888. doi: 10.1002/stem.2486. Epub 2016 Sep 13. Stem Cells. 2016. PMID: 27570947 Free PMC article.
-
The role of stem cells for treatment of cardiovascular disease.Cell Prolif. 2004 Feb;37(1):67-87. doi: 10.1111/j.1365-2184.2004.00301.x. Cell Prolif. 2004. PMID: 14871238 Free PMC article. Review.
-
Generation of novel reporter stem cells and their application for molecular imaging of cardiac-differentiated stem cells in vivo.Stem Cells Dev. 2010 Sep;19(9):1437-48. doi: 10.1089/scd.2009.0308. Stem Cells Dev. 2010. PMID: 20109065 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous